Results 151 to 160 of about 81,616 (201)
Some of the next articles are maybe not open access.
Trimethoprim-Sulfamethoxazole and Granulocytopenia
Annals of Internal Medicine, 1982Excerpt To the editor: We read with interest the article on prevention of infection by trimethoprim-sulfamethoxazole plus amphotericin B in patients with acute nonlymphocytic leukemia by Dekker and...
K M, Bakri, L P, Wasser
openaire +2 more sources
Trimethoprim-Sulfamethoxazole in Brucellosis
Journal of Infectious Diseases, 1973A clinical trial of the combination of trimethoprim and sulfamethoxazole (TMPSMZ), was conducted in 86 patients with brucellosis, hospitalized either in Trikala (Thessaly) or in Athens. All cases had the typical clinical picture of acute brucellosis, or that of special localizations and high titers of agglutination reactions in their sera.
G K, Daikos +5 more
openaire +2 more sources
Trimethoprim/Sulfamethoxazole Desensitization
Annals of Pharmacotherapy, 1996Although alternative therapy for PCP remains limited, the role of TMP/SMX desensitization becomes increasingly important in patients with AIDS. Various successful desensitization protocols have been described in this article. As there are no established guidelines, it appears that the desensitization procedure can occur in small successive doses given ...
L M, Cortese, D M, Soucy, T P, Endy
openaire +2 more sources
Mayo Clinic Proceedings, 1999
After 25 years of use in the United States, trimethoprim-sulfamethoxazole (TMP-SMX) is widely prescribed for various indications. By virtue of sequential blockade of microbial folic acid synthesis, the antimicrobial combination has excellent in vitro inhibitory activity against many common respiratory and urinary tract pathogens, as well as many ...
openaire +2 more sources
After 25 years of use in the United States, trimethoprim-sulfamethoxazole (TMP-SMX) is widely prescribed for various indications. By virtue of sequential blockade of microbial folic acid synthesis, the antimicrobial combination has excellent in vitro inhibitory activity against many common respiratory and urinary tract pathogens, as well as many ...
openaire +2 more sources
Trimethoprim-sulfamethoxazole and Immunosuppression
Scandinavian Journal of Rheumatology, 1988It has been suggested that many of the commonly used antimicrobial agents exert under experimental conditions an immunosuppressive effect at concentrations that not exceeding those necessary for therapeutical effect (1).
openaire +2 more sources
Trimethoprim-sulfamethoxazole desensitization in AIDS
Klinische Wochenschrift, 1988Trimethoprim-sulfamethoxazole (TMS) desensitization was carried out in three patients with AIDS and Pneumocystis carinii pneumonia (PCP) in whom treatment with TMS had to be discontinued after 8 to 12 days due to an allergic reaction. Although the pneumonia was under control we decided for a desensitization to TMS because of the frequent reinfection ...
G, Papakonstantinou +2 more
openaire +2 more sources
Trimethoprim-Sulfamethoxazole for Bacterial Meningitis
Annals of Internal Medicine, 1984Trimethoprim-sulfamethoxazole has excellent microbiologic activity against most pathogens that produce meningitis; both components of this drug have high penetration into tissues, including the cerebrospinal fluid. Clinical experience shows that trimethoprim-sulfamethoxazole may be beneficial in the treatment of gram-negative bacillary meningitis ...
R E, Levitz, R, Quintiliani
openaire +2 more sources
Trimethoprim-Sulfamethoxazole-Induced Hyponatremia
The Consultant Pharmacist, 2011An 86-year-old Caucasian male developed hyponatremia while on trimethoprim-sulfamethoxazole (TMP-SMX) 80/400 mg, one tablet by mouth twice daily. Upon discontinuation of therapy, his serum sodium and symptoms improved. He was inadvertently rechallenged several months later with TMP-SMX and had similar symptoms and laboratory abnormalities.
Rebecca L, Dunn +2 more
openaire +2 more sources
Trimethoprim-Sulfamethoxazole Induced Rhabdomyolysis
American Journal of Therapeutics, 2014Empiric antibiotic usage is very common in clinical practice and Trimethoprim-Sulfamethoxazole (TMP-SMX) is one such antibiotic used extensively in primary care practice. Some patients experience serious adverse effects to the antibiotics that markedly increase the morbidity and the cost of medical care.
Bujji, Ainapurapu, Uday B, Kanakadandi
openaire +2 more sources

